These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 8899084

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.
    Gunasekaran T, Gupta S, Gremse D, Karol M, Pan WJ, Chiu YL, Keith R, Fitzgerald J.
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S327-35. PubMed ID: 12607793
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I, Sagar M, Sjöstedt S, Hammarlund B, Iwarzon M, Seensalu R.
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.
    Bytzer P, Morocutti A, Kennerly P, Ravic M, Miller N, ROSE Trial Investigators.
    Scand J Gastroenterol; 2006 Oct; 41(10):1132-40. PubMed ID: 16990197
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
    Richter JE, Kovacs TO, Greski-Rose PA, Huang section sign B, Fisher R.
    Aliment Pharmacol Ther; 1999 Jun; 13(6):795-804. PubMed ID: 10383510
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    Zheng RN.
    World J Gastroenterol; 2009 Feb 28; 15(8):990-5. PubMed ID: 19248200
    [Abstract] [Full Text] [Related]

  • 32. Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis.
    Sharma VK, Leontiadis GI, Howden CW.
    Aliment Pharmacol Ther; 2001 Feb 28; 15(2):227-31. PubMed ID: 11148442
    [Abstract] [Full Text] [Related]

  • 33. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar 28; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 34. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study.
    Fass R, Murthy U, Hayden CW, Malagon IB, Pulliam G, Wendel C, Kovacs TO.
    Aliment Pharmacol Ther; 2000 Dec 28; 14(12):1595-603. PubMed ID: 11121907
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep 28; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 36. Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease.
    Wong WM, Lai KC, Hui WM, Lam KF, Huang JQ, Hu WH, Wong NY, Lam CL, Xia HH, Chan AO, Lam SK, Wong BC.
    Aliment Pharmacol Ther; 2004 Feb 15; 19(4):455-62. PubMed ID: 14871286
    [Abstract] [Full Text] [Related]

  • 37. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun 15; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec 15; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 39. Lansoprazole: in the management of gastroesophageal reflux disease in children.
    Scott LJ.
    Paediatr Drugs; 2003 Dec 15; 5(1):57-61; discussion 62. PubMed ID: 12513106
    [Abstract] [Full Text] [Related]

  • 40. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.
    Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekström P, Halvorsen L, Stallemo A, Hovdenak N, Trondstad R.
    Scand J Gastroenterol; 1993 Mar 15; 28(3):224-8. PubMed ID: 8446846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.